Volume 16, Number 7—July 2010
Endocarditis Caused by Actinobaculum schaalii, Austria
To the Editor: In May 2009, a 52-year-old man was hospitalized with middle cerebral artery stroke and fever of unknown origin. He had a complicated medical history of middle cerebral artery stroke and mechanical valve replacement of the aortic valve 2 years earlier and gastric-duodenal angiodysplasia. Two months before the most recent hospitalization, he had been hospitalized because of fever and anemia; blood cultures were positive; Gram stain identified coryneform rods that did not grow in culture. Antimicrobial drug therapy with levofloxacin (400 mg 1×/d) was initiated, and the patient was discharged.
At the most recent admission, laboratory testing showed a leukocyte count of 5.92 × 103 cells/μL, with 81% neutrophils, 7% lymphocytes, and 9% monocytes; thrombocyte count was 338 × 103 cells/μL. C-reactive protein level was 62.6 mg/L (reference value <8 mg/L). Basic serum and urine chemical profiles and urine culture were unremarkable. Empiric antimicrobial drug therapy with piperacillin–tazobactam (4.5 g 3×/d) was initiated and discontinued after 5 days because of clinical improvement. The next day, the patient’s condition deteriorated, C-reactive protein level increased from 15 mg/L to 32 mg/L, and blood was collected for culture on the day after piperacillin-tazobactam discontinuation and the next 2 days. After 4 days of incubation, bacterial growth was detected in 1 aerobic and 3 anaerobic samples. Gram stain showed positive coryneform rods. Within 48–72 hours, the isolate yielded growth on blood, chocolate, and Schaedler agar; colonies were 1–2 mm in diameter and gray. The specificity of the organism was unsatisfactory with the system we used (API Coryne system; bioMérieux, Craponne, France) (Table).
A 16S rRNA gene analysis was performed by using eubacterial universal primers. Subsequently, a BLAST search (www.ncbi.nlm.nih.gov/BLAST) of the partial 16S rRNA gene sequence (730 bp) was performed by using the taxonomy browser of the National Center for Biotechnology Information (www.ncbi.nlm.nih.gov). Homology of 99.7% (728/730 bp) was detected for Actinobaculum schaalii. The isolate was deposited in GenBank under accession no. GQ355962. MICs were obtained for various antimicrobial drugs, including amoxicillin–clavulanic acid (0.25 mg/L), piperacillin–tazobactam (0.125 mg/L), and levofloxacin (1 mg/L).
Infectious disease specialists were consulted. On physical examination, the patient exhibited Janeway lesions on hands and feet and a temperature of 38.4°C. Transesophageal echocardiogram showed filiform vegetation on the aortic valve, which was not consistent with echocardiographic major criteria. According to the modified Duke criteria (5), the patient’s condition fulfilled 1 major clinical criterion (at least 2 positive cultures of blood samples collected 12 hours apart) and 3 minor clinical criteria (prosthetic aortic valve, temperature >38°C, Janeway lesions). Accordingly, definite infective prosthetic valve endocarditis was diagnosed. Intravenous antimicrobial drug therapy with piperacillin-tazobactam (4.5 g 3×/d) was initiated, followed by oral therapy with amoxicillin–clavulanate acid (1 g 3×/d) for 8 weeks. Because a repeated transesophageal echocardiogram 10 days after initiation of antimicrobial drug therapy showed no infective endocarditis, heart surgeons declined to replace the prosthetic valve. The patient’s condition improved, and 2 weeks later he was discharged in good clinical condition.
Four species within the genus Actinobaculum have been described: A. massiliae (causing urinary tract infection [UTI] and superficial skin infection), A. urinale (isolated from human urine), A. suis, and A. schaalii (1,3,4,6). A. schaalii, which is difficult to identify by culture, has been reported to cause UTI in elderly patients with underlying urologic conditions; a few studies have reported subsequent urosepsis, abscess formations, and osteomyelitis (1,3,6–9). Recently, Bank et al. (7) reported development of a TaqMan real-time quantitative PCR for A. schaalii and consecutive detection of the organism in 22% of 252 routine urine samples of patients >60 years of age (8). Those findings suggest that A. schaalii is a common undetected pathogen, especially in elderly patients with unexplained chronic UTI.
We report infective endocarditis caused by A. schaalii. To our knowledge, infective endocarditis caused by Actinobaculum spp. has not been reported. However, several reports have documented endocarditis caused by Arcanobacterium spp. and Actinomyces spp., which are phylogenetically related to Actinobaculum spp. (10).
Characteristics of the patient reported here differed from those of patients in previous reports. He had no underlying urologic condition and could not recall any symptoms usually associated with UTI during the year before hospital admission. Urine culture remained negative for Actinobaculum spp. despite prolonged incubation for 5 days on chocolate agar in an atmosphere of 5% CO2 and on Schaedler agar under anaerobic conditions.
This report highlights the usefulness of the recent development of a specific real-time PCR by Bank et al. (7), which may prove effective not only for patients typically at risk for A. schaalii but also for patients with a wider spectrum of infection. More studies are needed to identify the real prevalence of disease caused by this difficult-to-cultivate organism because it may occur in many other groups of patients.
We thank Katharina Seeber for editorial assistance.
- Lawson PA, Falsen E, Akervall E, Vandamme P, Collins MD. Characterization of some Actinomyces-like isolates from human clinical specimens: reclassification of Actinomyces suis (Soltys and Spratling) as Actinobaculum suis comb. nov. and description of Actinobaculum schaalii sp. nov. Int J Syst Bacteriol. 1997;47:899–903.
- Reinhard M, Prag J, Kemp M, Andresen K, Klemmensen B, Hojlyng N. Ten cases of Actinobaculum schaalii infection: clinical relevance, bacterial identification, and antibiotic susceptibility. J Clin Microbiol. 2005;43:5305–8.
- Greub G, Raoult D. "Actinobaculum massiliae," a new species causing chronic urinary tract infection. [PubMed DOI]. J Clin Microbiol. 2002;40:3938–41.
- Hall V, Collins MD, Hutson RA, Falsen E, Inganas E, Duerden BI. Actinobaculum urinale sp. nov., from human urine. Int J Syst Evol Microbiol. 2003;53:679–82.
- Li JS, Sexton DJ, Mich N, Nettles R, Fowler VG Jr, Ryan T. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. [PubMed DOI]. Clin Infect Dis. 2000;30:633–8.
- Waghorn DJ. Actinobaculum massiliae: a new cause of superficial skin infection. J Infect. 2004;48:276–7.
- Bank S, Jensen A, Hansen TM, Soby KM, Prag J. Actinobaculum schaalii, a common uropathogen in elderly patients, Denmark. Emerg Infect Dis. 2010;16:76–80.
- Nielsen HL, Soby KM, Christensen JJ, Prag J. Actinobaculum schaalii: a common cause of urinary tract infection in the elderly population. Bacteriological and clinical characteristics. Scand J Infect Dis. 2010;42:43–7.
- Haller P, Bruderer T, Schaeren S, Laifer G, Frei R, Battegay M. Vertebral osteomyelitis caused by Actinobaculum schaalii: a difficult-to-diagnose and potentially invasive uropathogen. Eur J Clin Microbiol Infect Dis. 2007;26:667–70.
- Plamondon M, Martinez G, Raynal L, Touchette M, Valiquette L. A fatal case of Arcanobacterium pyogenes endocarditis in a man with no identified animal contact: case report and review of the literature. Eur J Clin Microbiol Infect Dis. 2007;26:663–6.
- Table. Comparison of isolated Actinobaculum schaalii with related human pathogens reported in the literature
Suggested citation for this article: Hoenigl M, Leitner E, Valentin T, Zarfel G, Salzer HJF, Krause R, et al. Endocarditis caused by Actinobaculum schaalii, Austria [letter]. Emerg Infect Dis [serial on the Internet]. 2010 Jul [date cited]. http://wwwnc.cdc.gov/eid/article/16/7/10-0349
Please use the form below to submit correspondence to the authors or contact them at the following address:
Andrea J. Grisold, Institute of Hygiene, Microbiology and Environmental Medicine, Medical University of Graz, Universitaetsplatz 4, A-8010 Graz, Austria
Comment submitted successfully, thank you for your feedback.
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
- Page created: March 02, 2011
- Page last updated: March 02, 2011
- Page last reviewed: March 02, 2011
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)